AbbVie Inc (ABBV)
167.25
-0.55
(-0.33%)
USD |
NYSE |
Apr 25, 16:00
166.25
-1.00
(-0.60%)
After-Hours: 20:00
AbbVie Gross Profit Margin (Quarterly): 60.11% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 60.11% |
| September 30, 2023 | 53.44% |
| June 30, 2023 | 69.42% |
| March 31, 2023 | 67.39% |
| December 31, 2022 | 72.42% |
| September 30, 2022 | 66.10% |
| June 30, 2022 | 71.41% |
| March 31, 2022 | 70.07% |
| December 31, 2021 | 70.98% |
| September 30, 2021 | 69.39% |
| June 30, 2021 | 67.60% |
| March 31, 2021 | 67.62% |
| December 31, 2020 | 66.20% |
| September 30, 2020 | 60.86% |
| June 30, 2020 | 64.40% |
| March 31, 2020 | 77.47% |
| December 31, 2019 | 76.95% |
| September 30, 2019 | 77.36% |
| June 30, 2019 | 77.96% |
| March 31, 2019 | 78.36% |
| December 31, 2018 | 75.65% |
| September 30, 2018 | 77.72% |
| June 30, 2018 | 76.64% |
| March 31, 2018 | 75.71% |
| December 31, 2017 | 70.53% |
| Date | Value |
|---|---|
| September 30, 2017 | 76.90% |
| June 30, 2017 | 77.98% |
| March 31, 2017 | 75.28% |
| December 31, 2016 | 77.13% |
| September 30, 2016 | 76.62% |
| June 30, 2016 | 78.22% |
| March 31, 2016 | 77.02% |
| December 31, 2015 | 76.95% |
| September 30, 2015 | 80.37% |
| June 30, 2015 | 83.27% |
| March 31, 2015 | 81.31% |
| December 31, 2014 | 79.48% |
| September 30, 2014 | 78.20% |
| June 30, 2014 | 77.41% |
| March 31, 2014 | 75.89% |
| December 31, 2013 | 74.92% |
| September 30, 2013 | 76.56% |
| June 30, 2013 | 77.54% |
| March 31, 2013 | 73.37% |
| December 31, 2012 | 75.70% |
| September 30, 2012 | 77.51% |
| June 30, 2012 | 76.12% |
| March 31, 2012 | 72.30% |
| December 31, 2011 | 75.83% |
| September 30, 2011 | 73.94% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
53.44%
Minimum
Sep 2023
77.96%
Maximum
Jun 2019
68.80%
Average
69.39%
Median
Sep 2021
Gross Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 62.03% |
| Immunogen Inc (DELISTED) | 98.10% |
| Johnson & Johnson | 69.55% |
| Eli Lilly and Co | 80.88% |
| Merck & Co Inc | 73.26% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 36.83% |
| Return on Assets | 3.58% |
| Return on Invested Capital | 6.53% |
| Profit Margin (Quarterly) | 5.75% |
| Operating Margin (Quarterly) | 24.31% |
| Return on Net Operating Assets | 4.26% |